Skip to main content
SpringerLink
Log in

Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial

  • Knee
  • Published:
Knee Surgery, Sports Traumatology, Arthroscopy Aims and scope

Abstract

Purpose

Despite the documented blood-saving effects of tranexamic acid (TNA) in total knee arthroplasty (TKA), the question whether clinical values of TNA are identical in unilateral and bilateral TKAs remains unclear. This study was undertaken to determine the clinical values of TNA in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol in terms of efficacy (total blood loss and transfusion rate) and safety (the incidences of symptomatic deep vein thrombosis and pulmonary embolism).

Methods

One hundred and eighty unilateral and 146 bilateral TKA patients were randomized into TNA group or control group. In unilateral TKA patients, TNA (10 mg/kg) was administered intravenously 20 min before tourniquet deflation and repeated 3 h after surgery. In bilateral TKA patients, one more dose (10 mg/kg) was given before tourniquet deflation in the second TKA. A contemporary blood-saving protocol was applied to all patients. The TNA and control groups were compared separately in unilateral and bilateral TKA patients for the efficacy and safety variables.

Results

In unilateral TKA patients, the TNA group had less total blood loss (905 vs. 1,018 mL, p = 0.018) than the control group, but there was no difference in the allogenic transfusion rate (1 vs. 7 %, n.s.). In bilateral TKA patients, the TNA group showed no differences in total blood loss (1,282 vs. 1,379 mL, n.s.), but a significant reduction in the allogenic transfusion rate (7 vs. 27 %, p = 0.002). No symptomatic deep vein thrombosis or pulmonary embolism was found in all patients.

Conclusion

This study demonstrates that the use of TNA reduces total blood loss, but the effects on the transfusion rate can differ depending on the type of TKAs (unilateral vs. bilateral) and the blood-saving protocols.

Level of evidence

Therapeutic study, Level I (double blind randomized controlled trial).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Alshryda S, Sarda P, Sukeik M, Nargol A et al (2011) Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Jt Surg Br 93:1577–1585

    Article  CAS  Google Scholar 

  2. Alvarez JC, Santiveri FX, Ramos I, Vela E et al (2008) Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion 48:519–525

    Article  PubMed  Google Scholar 

  3. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840

    CAS  PubMed  Google Scholar 

  4. Benoni G, Fredin H (1996) Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Jt Surg Br 78:434–440

    CAS  Google Scholar 

  5. Bong MR, Patel V, Chang E, Issack PS et al (2004) Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty 19:281–287

    Article  PubMed  Google Scholar 

  6. Borghi B, Casati A (2000) Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia. Eur J Anaesthesiol 17:411–417

    Article  CAS  PubMed  Google Scholar 

  7. Camarasa MA, Olle G, Serra-Prat M, Martin A et al (2006) Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth 96:576–582

    Article  CAS  PubMed  Google Scholar 

  8. Charoencholvanich K, Siriwattanasakul P (2011) Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res 469:2874–2880

    Article  PubMed Central  PubMed  Google Scholar 

  9. Cho HJ, Chang CB, Kim KW, Park JH et al (2011) Gender and prevalence of knee osteoarthritis types in elderly Koreans. J Arthroplasty 26:994–999

    Article  PubMed  Google Scholar 

  10. Coffey A, Pittmam J, Halbrook H, Fehrenbacher J et al (1995) The use of tranexamic acid to reduce postoperative bleeding following cardiac surgery: a double-blind randomized trial. Am Surg 61:566–568

    CAS  PubMed  Google Scholar 

  11. Dhillon MS, Bali K, Prabhakar S (2011) Tranexamic acid for control of blood loss in bilateral total knee replacement in a single stage. Indian J Orthop 45:148–152

    Article  PubMed Central  PubMed  Google Scholar 

  12. Dunn CJ, Goa KL (1999) Tranexamic acid: a review of its use in surgery and other indications. Drugs 57:1005–1032

    Article  CAS  PubMed  Google Scholar 

  13. Ellis MH, Fredman B, Zohar E, Ifrach N et al (2001) The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. J Clin Anesth 13:509–513

    Article  CAS  PubMed  Google Scholar 

  14. Engel JM, Hohaus T, Ruwoldt R, Menges T et al (2001) Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg 92:775–780

    Article  CAS  PubMed  Google Scholar 

  15. Fakhry SM, Fata P (2004) How low is too low? Cardiac risks with anemia. Crit Care 8(Suppl 2):S11–S14

    Article  PubMed Central  PubMed  Google Scholar 

  16. Good L, Peterson E, Lisander B (2003) Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 90:596–599

    Article  CAS  PubMed  Google Scholar 

  17. Hebert PC, Wells G, Blajchman MA, Marshall J et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417

    Article  CAS  PubMed  Google Scholar 

  18. Hiippala S, Strid L, Wennerstrand M, Arvela V et al (1995) Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth 74:534–537

    Article  CAS  PubMed  Google Scholar 

  19. Hiippala ST, Strid LJ, Wennerstrand MI, Arvela JV et al (1997) Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 84:839–844

    CAS  PubMed  Google Scholar 

  20. Ido K, Neo M, Asada Y, Kondo K et al (2000) Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg 120:518–520

    Article  CAS  PubMed  Google Scholar 

  21. Insall JN, Dorr LD, Scott RD, Scott WN (1989) Rationale of the knee society clinical rating system. Clin Orthop Relat Res 248:13–14

    PubMed  Google Scholar 

  22. Ishida K, Tsumura N, Kitagawa A, Hamamura S et al (2011) Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 35:1639–1645

    Article  PubMed Central  PubMed  Google Scholar 

  23. Jansen AJ, Andreica S, Claeys M, D’Haese J et al (1999) Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 83:596–601

    Article  CAS  PubMed  Google Scholar 

  24. Johanson NA, Lachiewicz PF, Lieberman JR, Lotke PA et al (2009) Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg 17:183–196

    PubMed  Google Scholar 

  25. Kakar PN, Gupta N, Govil P, Shah V (2009) Efficacy and safety of tranexamic acid in control of bleeding following tkr: a randomized clinical trial. Indian J Anaesth 53:667–671

    CAS  PubMed Central  PubMed  Google Scholar 

  26. Kim HA, Kim S, Seo YI, Choi HJ et al (2008) The epidemiology of total knee replacement in South Korea: national registry data. Rheumatology (Oxford) 47:88–91

    Article  Google Scholar 

  27. Lin PC, Hsu CH, Chen WS, Wang JW (2011) Does tranexamic acid save blood in minimally invasive total knee arthroplasty? Clin Orthop Relat Res 469:1995–2002

    Article  PubMed Central  PubMed  Google Scholar 

  28. MacGillivray RG, Tarabichi SB, Hawari MF, Raoof NT (2011) Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplasty 26:24–28

    Article  PubMed  Google Scholar 

  29. Maniar RN, Kumar G, Singhi T, Nayak RM et al (2012) Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 470:2605–2612

    Article  PubMed Central  PubMed  Google Scholar 

  30. McConnell JS, Shewale S, Munro NA, Shah K et al (2012) Reducing blood loss in primary knee arthroplasty: a prospective randomised controlled trial of tranexamic acid and fibrin spray. Knee 19:295–298

    Article  PubMed  Google Scholar 

  31. Molloy DO, Archbold HA, Ogonda L, McConway J et al (2007) Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Jt Surg Br 89:306–309

    Article  CAS  Google Scholar 

  32. Nadler SB, Hidalgo JH, Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51:224–232

    PubMed  Google Scholar 

  33. Onodera T, Majima T, Sawaguchi N, Kasahara Y et al (2012) Risk of deep venous thrombosis in drain clamping with tranexamic acid and carbazochrome sodium sulfonate hydrate in total knee arthroplasty. J Arthroplasty 27:105–108

    Article  PubMed  Google Scholar 

  34. Orpen NM, Little C, Walker G, Crawfurd EJ (2006) Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: a prospective randomised controlled trial of 29 patients. Knee 13:106–110

    Article  PubMed  Google Scholar 

  35. Pierson JL, Hannon TJ, Earles DR (2004) A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty. J Bone Jt Surg Am 86A:1512–1518

    Google Scholar 

  36. Rousou JA, Engelman RM, Flack JE 3rd, Deaton DW et al (1995) Tranexamic acid significantly reduces blood loss associated with coronary revascularization. Ann Thorac Surg 59:671–675

    Article  CAS  PubMed  Google Scholar 

  37. Roy SP, Tanki UF, Dutta A, Jain SK et al (2012) Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. doi:10.1007/s00167-012-1942-5

  38. Royston D (1995) Blood-sparing drugs: aprotinin, tranexamic acid, and epsilon-aminocaproic acid. Int Anesthesiol Clin 33:155–179

    Article  CAS  PubMed  Google Scholar 

  39. Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T et al (2009) Efficacy of tranexamic acid in reducing blood loss after cesarean section. J Matern Fetal Neonatal Med 22:72–75

    Article  CAS  PubMed  Google Scholar 

  40. Seo ES, Yoon SW, Koh IJ, Chang CB et al (2010) Subcutaneous versus intraarticular indwelling closed suction drainage after TKA: a randomized controlled trial. Clin Orthop Relat Res 468:2168–2176

    Article  PubMed Central  PubMed  Google Scholar 

  41. Seo JG, Moon YW, Park SH, Kim SM et al (2012) The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. doi:10.1007/s00167-012-2079-2

  42. Tanaka N, Sakahashi H, Sato E, Hirose K et al (2001) Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Jt Surg Br 83:702–705

    Article  CAS  Google Scholar 

  43. Veien M, Sorensen JV, Madsen F, Juelsgaard P (2002) Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand 46:1206–1211

    Article  CAS  PubMed  Google Scholar 

  44. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483

    Article  PubMed  Google Scholar 

  45. Wong J, Abrishami A, El Beheiry H, Mahomed NN et al (2010) Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Jt Surg Am 92:2503–2513

    Google Scholar 

  46. Yang ZG, Chen WP, Wu LD (2012) Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Jt Surg Am 94:1153–1159

    Article  Google Scholar 

  47. Zhang H, Chen J, Chen F, Que W (2011) The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 20:1742–1752

    Article  PubMed  Google Scholar 

  48. Zohar E, Ellis M, Ifrach N, Stern A et al (2004) The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 99:1679–1683

    Article  PubMed  Google Scholar 

  49. Zohar E, Fredman B, Ellis M, Luban I et al (1999) A comparative study of the postoperative allogeneic blood-sparing effect of tranexamic acid versus acute normovolemic hemodilution after total knee replacement. Anesth Analg 89:1382–1387

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Joint Reconstruction Center, Seoul National University Bundang Hospital, 166 Gumiro, Bundanggu, Seongnamsi, 463-707, Gyeonggido, Republic of Korea

    Tae Kyun Kim, Chong Bum Chang & Yeon Gwi Kang

  2. Department of Orthopaedic Surgery, National Medical Center, Seoul, Republic of Korea

    Eun Seok Seo

  3. Department of Orthopaedic Surgery, National Police Hospital, Seoul, Republic of Korea

    Jung Ha Lee

  4. Department of Orthopaedic Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea

    Tae Kyun Kim, Chong Bum Chang, Joung Ho Yun & Sun Hyung Lee

Authors
  1. Tae Kyun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chong Bum Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yeon Gwi Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eun Seok Seo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jung Ha Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joung Ho Yun
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sun Hyung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tae Kyun Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, T.K., Chang, C.B., Kang, Y.G. et al. Clinical value of tranexamic acid in unilateral and simultaneous bilateral TKAs under a contemporary blood-saving protocol: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 22, 1870–1878 (2014). https://doi.org/10.1007/s00167-013-2492-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00167-013-2492-1

Keywords

Search

Navigation